| Literature DB >> 33538798 |
Vivien Kohlhaas1,2,3,4,5, Stuart James Blakemore3,4,6, Mona Al-Maarri1,2,3,4,5, Nadine Nickel3,4,6, Martin Pal1,2,3,4,5, Andreas Roth3,4,6, Nadine Hövelmeyer7, Stephan C Schäfer8, Gero Knittel3,4,6, Philipp Lohneis8, Milos Nikolic4,9, Janica L Wiederstein3,9, Marek Franitza10, Theodoros Georgomonolis10,11, Nina Reinart3,4,6, Marco Herling3,4,6, Carmen Herling3,4,6, Elena M Hartmann12, Andreas Rosenwald12, Wolfram Klapper13, Reinhard Büttner8, Riccardo Moia14, Davide Rossi15,16, Renzo Boldorini14,17, Gianluca Gaidano17, Lukas P Frenzel3,4,6, Hans Christian Reinhardt3,4,6,18, Jens C Brüning1,2,3,4,5, Michael Hallek3,4,6, Marcus Krüger3,9, Martin Peifer4,9, Christian P Pallasch3,4,6, F Thomas Wunderlich1,2,3,4,5.
Abstract
Richter's transformation (RT) is an aggressive lymphoma that occurs upon progression from chronic lymphocytic leukemia (CLL). Transformation has been associated with genetic aberrations in the CLL phase involving TP53, CDKN2A, MYC, and NOTCH1; however, a significant proportion of RT cases lack CLL phase-associated events. Here, we report that high levels of AKT phosphorylation occur both in high-risk CLL patients harboring TP53 and NOTCH1 mutations as well as in patients with RT. Genetic overactivation of Akt in the murine Eµ-TCL1 CLL mouse model resulted in CLL transformation to RT with significantly reduced survival and an aggressive lymphoma phenotype. In the absence of recurrent mutations, we identified a profile of genomic aberrations intermediate between CLL and diffuse large B-cell lymphoma. Multiomics assessment by phosphoproteomic/proteomic and single-cell transcriptomic profiles of this Akt-induced murine RT revealed an S100 protein-defined subcluster of highly aggressive lymphoma cells that developed from CLL cells, through activation of Notch via Notch ligand expressed by T cells. Constitutively active Notch1 similarly induced RT of murine CLL. We identify Akt activation as an initiator of CLL transformation toward aggressive lymphoma by inducing Notch signaling between RT cells and microenvironmental T cells.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33538798 DOI: 10.1182/blood.2020005734
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113